KAIRAV PRAMESH VAKIL

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease MINNEAPOLIS, MN NPI 1467600403

General Payments — all program years on this page

$17,109.89

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 54
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $15,304.37 across 30 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $10,743.8412
Abbott Laboratories $4,187.7214
Edwards Lifesciences Corporation $292.732
IMPULSE DYNAMICS (USA) INC. $65.891
BOSTON SCIENTIFIC CORPORATION $14.191

By program year

Program yearAmountRecords
2018 $160.151
2019 $560.907
2021 $173.695
2022 $385.696
2023 $525.095
2024 $15,304.3730

Records — PY2024 (30)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092542682 Boston Scientific Corporation $14.19 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100413350 Impulse Dynamics (USA) Inc. $65.89 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104250549 AstraZeneca Pharmaceuticals LP $4,300.00 07/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1104272653 AstraZeneca Pharmaceuticals LP $100.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1104497220 AstraZeneca Pharmaceuticals LP $120.01 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104500232 AstraZeneca Pharmaceuticals LP $2,150.00 11/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1104776980 AstraZeneca Pharmaceuticals LP $22.78 10/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105372741 AstraZeneca Pharmaceuticals LP $100.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1105442551 AstraZeneca Pharmaceuticals LP $30.00 07/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105465989 AstraZeneca Pharmaceuticals LP $491.69 07/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105489125 AstraZeneca Pharmaceuticals LP $1,050.00 11/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1105644054 AstraZeneca Pharmaceuticals LP $64.72 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105656204 AstraZeneca Pharmaceuticals LP $164.64 07/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1105706092 AstraZeneca Pharmaceuticals LP $2,150.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1125079627 Abbott Laboratories $133.29 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079629 Abbott Laboratories $11.79 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079631 Abbott Laboratories $84.72 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079633 Abbott Laboratories $9.79 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079635 Abbott Laboratories $32.64 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079637 Abbott Laboratories $32.64 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079639 Abbott Laboratories $4.52 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125079641 Abbott Laboratories $32.64 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125411688 Abbott Laboratories $1,375.00 09/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125411690 Abbott Laboratories $1,375.00 09/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1125411692 Abbott Laboratories $43.75 12/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125411694 Abbott Laboratories $750.06 12/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125411696 Abbott Laboratories $292.86 12/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1125411698 Abbott Laboratories $9.02 12/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1138886525 Edwards Lifesciences Corporation $112.94 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138886583 Edwards Lifesciences Corporation $179.79 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.